It has been reported that, when EZH2 was knocked down in PCa, IFNGR1 expression was restored, and when IFN therapy was applied, significant activation of IFN-JAK-STAT1 tumor suppressor signaling occurred [69]. The gene discussed is IFNGR1; the disease is posterior cortical atrophy.